HEADER HYDROLASE 23-JUL-15 5CS2
TITLE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM DIADENOSINE TRIPHOSPHATE
TITLE 2 HYDROLASE IN COMPLEX WITH CYCLOMARIN A
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HISTIDINE TRIAD PROTEIN;
COMPND 3 CHAIN: A;
COMPND 4 ENGINEERED: YES;
COMPND 5 MOL_ID: 2;
COMPND 6 MOLECULE: CYCLOMARIN A;
COMPND 7 CHAIN: B
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM 3D7;
SOURCE 3 ORGANISM_TAXID: 36329;
SOURCE 4 STRAIN: ISOLATE 3D7;
SOURCE 5 GENE: PF14_0349;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_VARIANT: T1 RESISTANT;
SOURCE 9 MOL_ID: 2;
SOURCE 10 ORGANISM_SCIENTIFIC: STREPTOMYCES;
SOURCE 11 ORGANISM_TAXID: 1883
KEYWDS CYCLOMARIN A, DIADENOSINE TRIPHOSPHATE HYDROLASE, ANTI-PLASMODIAL
KEYWDS 2 ACTIVITY, MALARIA, PLASMODIUM FALCIPARUM, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR N.OSTERMANN,E.SCHMITT,B.GERHARTZ,A.HINNIGER,C.DELMAS
REVDAT 5 20-NOV-24 5CS2 1 ATOM
REVDAT 4 10-JAN-24 5CS2 1 SOURCE LINK ATOM
REVDAT 3 15-MAY-19 5CS2 1 SEQRES
REVDAT 2 27-JAN-16 5CS2 1 JRNL
REVDAT 1 28-OCT-15 5CS2 0
JRNL AUTH N.BURSTNER,S.ROGGO,N.OSTERMANN,J.BLANK,C.DELMAS,F.FREULER,
JRNL AUTH 2 B.GERHARTZ,A.HINNIGER,D.HOEPFNER,B.LIECHTY,M.MIHALIC,
JRNL AUTH 3 J.MURPHY,D.PISTORIUS,M.ROTTMANN,J.R.THOMAS,M.SCHIRLE,
JRNL AUTH 4 E.K.SCHMITT
JRNL TITL GIFT FROM NATURE: CYCLOMARIN A KILLS MYCOBACTERIA AND
JRNL TITL 2 MALARIA PARASITES BY DISTINCT MODES OF ACTION.
JRNL REF CHEMBIOCHEM V. 16 2433 2015
JRNL REFN ESSN 1439-7633
JRNL PMID 26472355
JRNL DOI 10.1002/CBIC.201500472
REMARK 2
REMARK 2 RESOLUTION. 1.65 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.5
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.50
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5
REMARK 3 NUMBER OF REFLECTIONS : 20891
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.197
REMARK 3 R VALUE (WORKING SET) : 0.195
REMARK 3 FREE R VALUE : 0.223
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1044
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 10
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.74
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.49
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3034
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2398
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2883
REMARK 3 BIN R VALUE (WORKING SET) : 0.2377
REMARK 3 BIN FREE R VALUE : 0.2812
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.98
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 151
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1303
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 1
REMARK 3 SOLVENT ATOMS : 111
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 26.19
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.74
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -4.17580
REMARK 3 B22 (A**2) : -4.17580
REMARK 3 B33 (A**2) : 8.35170
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.238
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.104
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.099
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.099
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.096
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 1339 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 1810 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 478 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 38 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 182 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 1339 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 180 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 1577 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.07
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.35
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.97
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5CS2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-JUL-15.
REMARK 100 THE DEPOSITION ID IS D_1000212098.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 05-NOV-14
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X10SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.99997
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20919
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650
REMARK 200 RESOLUTION RANGE LOW (A) : 17.500
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5
REMARK 200 DATA REDUNDANCY : 8.000
REMARK 200 R MERGE (I) : 0.05100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 7.20
REMARK 200 R MERGE FOR SHELL (I) : 0.75000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 2FHI
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 27.97
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.71
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 UL OF PROTEIN-INHIBITOR SOLUTION
REMARK 280 (11 MG/ML PFAP3AASE, 50 MM TRIS PH 8, 150 MM NACL, 5% GLYCEROL
REMARK 280 AND 1 MM TCEP, 1MM CYCLOMARIN A) WAS MIXED WITH 0.2 UL RESERVOIR
REMARK 280 SOLUTION (100 MM HEPES PH 7.5, 30% ISO-PROPANOL, 200 MM
REMARK 280 MAGNESIUM CHLORIDE HEXAHYDRATE) AND EQUILIBRATED AGAINST 80 UL
REMARK 280 RESERVOIR SOLUTION., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE
REMARK 280 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+2/3
REMARK 290 3555 -X+Y,-X,Z+1/3
REMARK 290 4555 Y,X,-Z
REMARK 290 5555 X-Y,-Y,-Z+1/3
REMARK 290 6555 -X,-X+Y,-Z+2/3
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 92.29333
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.14667
REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 46.14667
REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 92.29333
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 68.92950
REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 -39.79647
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 0
REMARK 465 PRO A 1
REMARK 465 TYR A 126
REMARK 465 LYS A 127
REMARK 465 ASN A 128
REMARK 465 ASN A 129
REMARK 465 ASP A 130
REMARK 465 ASN A 131
REMARK 465 ILE A 132
REMARK 465 TYR A 133
REMARK 465 ASN A 134
REMARK 465 ASP A 135
REMARK 465 MET A 136
REMARK 465 ASN A 137
REMARK 465 LYS A 138
REMARK 465 ILE A 139
REMARK 465 ASN A 140
REMARK 465 LEU A 141
REMARK 465 GLY A 142
REMARK 465 TYR A 143
REMARK 465 GLY A 144
REMARK 465 LYS A 145
REMARK 465 ASN A 146
REMARK 465 ILE A 147
REMARK 465 ILE A 148
REMARK 465 CYS A 149
REMARK 465 ASN A 150
REMARK 465 SER A 151
REMARK 465 CYS A 152
REMARK 465 ASN A 153
REMARK 465 ASN A 154
REMARK 465 THR A 155
REMARK 465 ILE A 156
REMARK 465 ASN A 157
REMARK 465 VAL A 158
REMARK 465 CYS A 159
REMARK 465 SER A 160
REMARK 465 GLN A 161
REMARK 465 ASN A 162
REMARK 465 GLU A 163
REMARK 465 ILE A 164
REMARK 465 GLU A 165
REMARK 465 ARG A 166
REMARK 465 ASN A 167
REMARK 465 PHE A 168
REMARK 465 LYS A 169
REMARK 465 LEU A 170
REMARK 465 GLU A 171
REMARK 465 GLU A 172
REMARK 465 PHE A 173
REMARK 465 ASN A 174
REMARK 465 THR A 175
REMARK 465 SER A 176
REMARK 465 SER A 200
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA B 3 -17.92 -144.52
REMARK 500 ALA B 3 -17.91 -144.51
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1000
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues 54C B 1 and WVL B 7
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues 54C B 1 and WLU B 2
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues WLU B 2 and WPA B 4
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues MLE B 6 and WVL B 7
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues MLE B 6 and WVL B 7
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues MLE B 6 and WVL B 7
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues MLE B 6 and WVL B 7
DBREF 5CS2 A 2 200 UNP Q8IL97 Q8IL97_PLAF7 2 200
DBREF 5CS2 B 1 7 PDB 5CS2 5CS2 1 7
SEQADV 5CS2 GLY A 0 UNP Q8IL97 EXPRESSION TAG
SEQADV 5CS2 PRO A 1 UNP Q8IL97 EXPRESSION TAG
SEQRES 1 A 201 GLY PRO GLU LYS TYR LYS ASN ILE LEU GLU LYS LEU GLU
SEQRES 2 A 201 TRP TYR LYS ASN LYS SER SER GLU LYS TYR GLU PHE GLY
SEQRES 3 A 201 ILE TYR GLU ILE ASP LYS ARG GLU VAL PHE ILE THR THR
SEQRES 4 A 201 LYS TYR SER TYR GLY PHE VAL ASN ASN LYS PRO LEU LEU
SEQRES 5 A 201 PRO GLY HIS ILE LEU LEU THR THR LEU LYS LYS LYS LYS
SEQRES 6 A 201 HIS TYR ASN ASP LEU ASP ILE GLU GLU ILE ILE ASP ILE
SEQRES 7 A 201 ASN LEU LEU CYS ASN PHE MET CYS TYR ILE MET GLY ASN
SEQRES 8 A 201 LEU PHE ASN THR THR ASP PHE SER ILE ALA ILE GLN ASP
SEQRES 9 A 201 GLY LYS GLU ALA GLY GLN THR VAL ASP HIS VAL HIS ILE
SEQRES 10 A 201 HIS ILE ILE PRO ARG LYS ILE ASN ASP TYR LYS ASN ASN
SEQRES 11 A 201 ASP ASN ILE TYR ASN ASP MET ASN LYS ILE ASN LEU GLY
SEQRES 12 A 201 TYR GLY LYS ASN ILE ILE CYS ASN SER CYS ASN ASN THR
SEQRES 13 A 201 ILE ASN VAL CYS SER GLN ASN GLU ILE GLU ARG ASN PHE
SEQRES 14 A 201 LYS LEU GLU GLU PHE ASN THR SER ILE ARG SER ILE GLU
SEQRES 15 A 201 GLN MET GLU GLU GLU ALA ASN LEU ILE LYS SER TYR ILE
SEQRES 16 A 201 ASN GLU LYS PHE SER SER
SEQRES 1 B 7 54C WLU ALA WPA VAL MLE WVL
HET 54C B 1 42
HET WLU B 2 20
HET WPA B 4 26
HET MLE B 6 18
HET WVL B 7 20
HET CL A1000 1
HETNAM 54C (BETAR)-BETA-HYDROXY-1-{2-[(2R)-OXIRAN-2-YL]PROPAN-2-
HETNAM 2 54C YL}-L-TRYPTOPHAN
HETNAM WLU (4R)-5-HYDROXY-N-METHYL-L-LEUCINE
HETNAM WPA (BETAR)-BETA-METHOXY-L-PHENYLALANINE
HETNAM MLE N-METHYLLEUCINE
HETNAM WVL (2S,3R)-2-AMINO-3,5-DIMETHYLHEX-4-ENOIC ACID
HETNAM CL CHLORIDE ION
FORMUL 2 54C C16 H20 N2 O4
FORMUL 2 WLU C7 H15 N O3
FORMUL 2 WPA C10 H13 N O3
FORMUL 2 MLE C7 H15 N O2
FORMUL 2 WVL C8 H15 N O2
FORMUL 3 CL CL 1-
FORMUL 4 HOH *111(H2 O)
HELIX 1 AA1 GLU A 2 LEU A 11 1 10
HELIX 2 AA2 ASP A 30 ARG A 32 5 3
HELIX 3 AA3 HIS A 65 LEU A 69 5 5
HELIX 4 AA4 ASP A 70 ASN A 93 1 24
HELIX 5 AA5 GLY A 104 GLY A 108 5 5
HELIX 6 AA6 SER A 179 SER A 199 1 21
SHEET 1 AA1 2 GLU A 23 PHE A 24 0
SHEET 2 AA1 2 TYR A 27 GLU A 28 -1 O TYR A 27 N PHE A 24
SHEET 1 AA2 5 VAL A 34 THR A 37 0
SHEET 2 AA2 5 SER A 41 VAL A 45 -1 O GLY A 43 N ILE A 36
SHEET 3 AA2 5 ILE A 55 THR A 59 -1 O LEU A 56 N PHE A 44
SHEET 4 AA2 5 HIS A 115 ARG A 121 -1 O ILE A 116 N LEU A 57
SHEET 5 AA2 5 ASP A 96 ALA A 100 -1 N ALA A 100 O HIS A 117
LINK C A54C B 1 N AWLU B 2 1555 1555 1.37
LINK C B54C B 1 N BWLU B 2 1555 1555 1.37
LINK N A54C B 1 C AWVL B 7 1555 1555 1.35
LINK N B54C B 1 C BWVL B 7 1555 1555 1.35
LINK C AWLU B 2 N AALA B 3 1555 1555 1.35
LINK C BWLU B 2 N BALA B 3 1555 1555 1.35
LINK CG2AWLU B 2 CE2AWPA B 4 1555 4645 1.26
LINK CG2BWLU B 2 CE2BWPA B 4 1555 4645 1.26
LINK C AALA B 3 N AWPA B 4 1555 1555 1.36
LINK C BALA B 3 N BWPA B 4 1555 1555 1.36
LINK C AWPA B 4 N AVAL B 5 1555 1555 1.36
LINK C BWPA B 4 N BVAL B 5 1555 1555 1.36
LINK C AVAL B 5 N AMLE B 6 1555 1555 1.37
LINK C BVAL B 5 N BMLE B 6 1555 1555 1.37
LINK N AVAL B 5 C AWVL B 7 1555 4645 1.42
LINK N BVAL B 5 C BWVL B 7 1555 4645 1.42
LINK CA AVAL B 5 CA AWVL B 7 1555 4645 1.27
LINK CA AVAL B 5 CB AWVL B 7 1555 4645 1.31
LINK CA AVAL B 5 C AWVL B 7 1555 4645 1.45
LINK CA BVAL B 5 C BWVL B 7 1555 4645 1.45
LINK CA BVAL B 5 CA BWVL B 7 1555 4645 1.27
LINK CA BVAL B 5 CB BWVL B 7 1555 4645 1.31
LINK C AVAL B 5 C AWVL B 7 1555 4645 1.62
LINK C AVAL B 5 N AWVL B 7 1555 4645 1.26
LINK C BVAL B 5 C BWVL B 7 1555 4645 1.62
LINK C BVAL B 5 N BWVL B 7 1555 4645 1.26
LINK O AVAL B 5 CA AWVL B 7 1555 4645 1.33
LINK O AVAL B 5 C AWVL B 7 1555 4645 1.48
LINK O BVAL B 5 C BWVL B 7 1555 4645 1.49
LINK O BVAL B 5 CA BWVL B 7 1555 4645 1.33
LINK CB AVAL B 5 CG1AWVL B 7 1555 4645 1.18
LINK CB AVAL B 5 CD AWVL B 7 1555 4645 1.38
LINK CB BVAL B 5 CG1BWVL B 7 1555 4645 1.18
LINK CB BVAL B 5 CD BWVL B 7 1555 4645 1.38
LINK CG1AVAL B 5 CD AWVL B 7 1555 4645 1.59
LINK CG1BVAL B 5 CD BWVL B 7 1555 4645 1.59
LINK CG2AVAL B 5 CD AWVL B 7 1555 4645 1.15
LINK CG2BVAL B 5 CD BWVL B 7 1555 4645 1.15
LINK C AMLE B 6 N AWVL B 7 1555 1555 1.35
LINK C BMLE B 6 N BWVL B 7 1555 1555 1.35
LINK N AMLE B 6 CA AWVL B 7 1555 4645 1.56
LINK N AMLE B 6 N AWVL B 7 1555 4645 1.18
LINK N BMLE B 6 N BWVL B 7 1555 4645 1.18
LINK N BMLE B 6 CA BWVL B 7 1555 4645 1.56
LINK CB AMLE B 6 CG2AWVL B 7 1555 4645 1.52
LINK CB BMLE B 6 CG2BWVL B 7 1555 4645 1.52
CISPEP 1 54C B 1 WLU B 2 0 2.90
CISPEP 2 54C B 1 WLU B 2 0 2.94
CISPEP 3 VAL B 5 MLE B 6 0 3.03
CISPEP 4 VAL B 5 MLE B 6 0 3.10
SITE 1 AC1 3 GLY A 25 ILE A 26 ASP A 112
SITE 1 AC2 11 GLN A 102 GLU A 106 ALA A 107 GLY A 108
SITE 2 AC2 11 THR A 110 ARG A 121 WLU B 2 ALA B 3
SITE 3 AC2 11 WPA B 4 VAL B 5 MLE B 6
SITE 1 AC3 10 GLN A 102 GLU A 106 ALA A 107 GLY A 108
SITE 2 AC3 10 THR A 110 ARG A 121 ALA B 3 WPA B 4
SITE 3 AC3 10 VAL B 5 WVL B 7
SITE 1 AC4 5 54C B 1 ALA B 3 VAL B 5 MLE B 6
SITE 2 AC4 5 WVL B 7
SITE 1 AC5 7 HIS A 117 ARG A 121 HOH A1123 54C B 1
SITE 2 AC5 7 ALA B 3 WPA B 4 VAL B 5
SITE 1 AC6 7 HIS A 117 ARG A 121 HOH A1123 54C B 1
SITE 2 AC6 7 ALA B 3 WPA B 4 VAL B 5
SITE 1 AC7 7 HIS A 117 ARG A 121 HOH A1123 54C B 1
SITE 2 AC7 7 ALA B 3 WPA B 4 VAL B 5
SITE 1 AC8 7 HIS A 117 ARG A 121 HOH A1123 54C B 1
SITE 2 AC8 7 ALA B 3 WPA B 4 VAL B 5
CRYST1 45.953 45.953 138.440 90.00 90.00 120.00 P 32 2 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021761 0.012564 0.000000 0.00000
SCALE2 0.000000 0.025128 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007223 0.00000